Condition
Cutis Laxa
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Completed2
Terminated1
Enrolling By Invitation1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06330350Recruiting
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
NCT06330324Enrolling By Invitation
Reproductive Options in Inherited Skin Diseases
NCT03887208Phase 1Completed
Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells
NCT01293864TerminatedPrimary
Structural Analysis of Human Tissue
NCT01658163Completed
Use of 2-octyl-cyanoacrylate Together With a Self-adhering Mesh
Showing all 5 trials